HIGHLIGHTS
- who: Advanced Cirrhosis and colleagues from the Pharmacy, University of Louisville Hospital, Louisville, USA Internal Medicine, University of Louisville, Louisville have published the research: Review began 04/04/2022 Review ended 04/09/2022 Published 04/11/2022 u00a9 Copyright, in the Journal: (JOURNAL) of April/11,/2022
- what: The aim of this medication use evaluation was to assess the use of DOACs specifically apixaban and rivaroxaban in patients with Methods: The study demonstrated that it may be possible to safely use DOACs in patients with Further studies are needed to evaluate the safety and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.